Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDChina Pharma Holdings Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
China Pharma Holdings Inc. Earnings Date And Information
China Pharma Holdings Inc. last posted its earnings results on Friday, November 11th, 2011. The company reported $0.8 earnings per share for the quarter, missing analysts' consensus estimates of $1.2 by $0.4. The company had revenue of 756.22 K for the quarter and had revenue of 4.53 M for the year. China Pharma Holdings Inc. has generated $0 earnings per share over the last year ($-0.27 diluted earnings per share) and currently has a price-to-earnings ratio of -0.85. China Pharma Holdings Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
China Pharma Holdings Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/12/2025 | Q3 2025 | N/A | -$0.17 | N/A | $756.22 K | $756.22 K |
| 08/14/2025 | Q2 2025 | N/A | -$0.16 | N/A | N/A | $1.03 M |
| 05/14/2025 | Q1 2025 | N/A | -$0.18 | N/A | N/A | $1.14 M |
| 03/31/2025 | Q4 2024 | N/A | -$0.26 | N/A | N/A | $1.13 M |
| 11/13/2024 | Q3 2024 | N/A | -$0.23 | N/A | N/A | $1.10 M |
| 08/14/2024 | Q2 2024 | N/A | -$0.30 | N/A | N/A | $924.94 K |
| 05/15/2024 | Q1 2024 | N/A | -$0.20 | N/A | N/A | $1.37 M |
| 04/01/2024 | Q4 2023 | N/A | -$0.26 | N/A | N/A | $2.15 M |
| 11/13/2023 | Q3 2023 | N/A | -$0.16 | N/A | N/A | $1.80 M |
| 08/14/2023 | Q2 2023 | N/A | -$0.12 | N/A | N/A | $1.10 M |
| 05/12/2023 | Q1 2023 | N/A | -$0.10 | N/A | N/A | $1.96 M |
| 03/30/2023 | Q4 2022 | N/A | -$0.21 | N/A | N/A | $2.92 M |
| 11/14/2022 | Q3 2022 | N/A | -$0.79 | N/A | N/A | $1.97 M |
| 08/11/2022 | Q2 2022 | N/A | -$0.51 | N/A | N/A | $1.61 M |
| 05/12/2022 | Q1 2022 | N/A | -$0.57 | N/A | N/A | $1.60 M |
| 03/30/2022 | Q4 2021 | N/A | -$0.64 | N/A | N/A | $2.89 M |
| 11/12/2021 | Q3 2021 | N/A | -$0.18 | N/A | N/A | $1.98 M |
| 08/13/2021 | Q2 2021 | N/A | -$0.18 | N/A | N/A | $2.42 M |
| 05/14/2021 | Q1 2021 | N/A | -$0.17 | N/A | N/A | $2.36 M |
| 03/26/2021 | Q4 2020 | N/A | -$0.28 | N/A | N/A | $2.93 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
China Pharma Holdings Inc. Earnings: FAQ's
The conference call for China Pharma Holdings Inc.'s latest earnings report can be listened to online.
The conference call transcript for China Pharma Holdings Inc.'s latest earnings report can be read online.
China Pharma Holdings Inc. (:CPHI) has a recorded annual revenue of $4.53 M.
China Pharma Holdings Inc. (:CPHI) has a recorded net income of $-4,736,365.China Pharma Holdings Inc. has generated $-0.27 earnings per share over the last four quarters.
China Pharma Holdings Inc. (:CPHI) has a price-to-earnings ratio of -0.85 and price/earnings-to-growth ratio is -0.12.